THROMBOGENICS
THROMBOGENICS operates in Diversified Metals & Mining.
Market Cap & Net Worth: THROMBOGENICS (TG4)
THROMBOGENICS (BE:TG4) has a market capitalization of $9.93K (€9.67K) as of March 18, 2026. Listed on the BE stock exchange, this Germany-based company holds position #45030 globally and #7426 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying THROMBOGENICS's stock price €1.00 by its total outstanding shares 9672 (9.67K).
THROMBOGENICS Market Cap History: 2015 to 2024
THROMBOGENICS's market capitalization history from 2015 to 2024. Data shows change from $34.44K to $9.93K (-68.60% CAGR).
THROMBOGENICS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how THROMBOGENICS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.19x
THROMBOGENICS's market cap is 0.19 times its annual revenue
0.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $241.85 Million | $7.10 Million | -$60.31 Million | 34.04x | N/A |
| 2017 | $329.61 Million | $9.05 Million | $22.79 Million | 36.40x | 14.46x |
| 2018 | $329.11 Million | $5.32 Million | -$38.47 Million | 61.86x | N/A |
| 2019 | $275.50 Million | $3.95 Million | -$51.83 Million | 69.82x | N/A |
| 2020 | $255.65 Million | $2.08 Million | -$28.01 Million | 123.03x | N/A |
| 2021 | $174.34 Million | $1.13 Million | -$29.16 Million | 154.55x | N/A |
| 2022 | $1.77 Million | $595.00K | -$31.68 Million | 2.97x | N/A |
| 2023 | $49.64K | $263.00K | -$18.97 Million | 0.19x | N/A |
Competitor Companies of TG4 by Market Capitalization
Companies near THROMBOGENICS in the global market cap rankings as of March 18, 2026.
Key companies related to THROMBOGENICS by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
THROMBOGENICS Historical Marketcap From 2015 to 2024
Between 2015 and today, THROMBOGENICS's market cap moved from $34.44K to $ 9.93K, with a yearly change of -68.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €9.93K | -80.00% |
| 2023 | €49.64K | -97.19% |
| 2022 | €1.77 Million | -98.99% |
| 2021 | €174.34 Million | -31.81% |
| 2020 | €255.65 Million | -7.21% |
| 2019 | €275.50 Million | -16.29% |
| 2018 | €329.11 Million | -0.15% |
| 2017 | €329.61 Million | +36.29% |
| 2016 | €241.85 Million | +702119.66% |
| 2015 | €34.44K | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2025 the market cap of THROMBOGENICS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.93K USD |
| MoneyControl | $9.93K USD |
| MarketWatch | $9.93K USD |
| marketcap.company | $9.93K USD |
| Reuters | $9.93K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.